Lite Strategy, Inc. (LITS)
1.04
+0.05
(+5.08%)
USD |
NASDAQ |
Aug 24, 16:00
1.07
+0.03
(+2.88%)
After-Hours: 20:00
Lite Strategy Max Drawdown (5Y) : 98.64% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 98.64% |
| June 30, 2026 | 98.64% |
| May 31, 2026 | 98.64% |
| April 30, 2026 | 98.64% |
| March 31, 2026 | 98.64% |
| February 28, 2026 | 98.64% |
| January 31, 2026 | 98.27% |
| December 31, 2025 | 98.12% |
| November 30, 2025 | 97.57% |
| October 31, 2025 | 97.36% |
| September 30, 2025 | 97.34% |
| August 31, 2025 | 97.34% |
| July 31, 2025 | 97.34% |
| June 30, 2025 | 97.34% |
| May 31, 2025 | 97.34% |
| April 30, 2025 | 97.34% |
| March 31, 2025 | 96.87% |
| February 28, 2025 | 96.63% |
| January 31, 2025 | 96.63% |
| December 31, 2024 | 96.63% |
| November 30, 2024 | 96.19% |
| October 31, 2024 | 96.19% |
| September 30, 2024 | 96.03% |
| August 31, 2024 | 96.03% |
| July 31, 2024 | 96.03% |
| Date | Value |
|---|---|
| June 30, 2024 | 96.03% |
| May 31, 2024 | 95.92% |
| April 30, 2024 | 95.76% |
| March 31, 2024 | 95.76% |
| February 29, 2024 | 95.76% |
| January 31, 2024 | 95.76% |
| December 31, 2023 | 95.76% |
| November 30, 2023 | 95.76% |
| October 31, 2023 | 95.76% |
| September 30, 2023 | 95.76% |
| August 31, 2023 | 95.76% |
| July 31, 2023 | 95.76% |
| June 30, 2023 | 95.76% |
| May 31, 2023 | 95.76% |
| April 30, 2023 | 95.76% |
| March 31, 2023 | 95.76% |
| February 28, 2023 | 95.76% |
| January 31, 2023 | 95.61% |
| December 31, 2022 | 95.61% |
| November 30, 2022 | 93.86% |
| October 31, 2022 | 93.40% |
| September 30, 2022 | 92.19% |
| August 31, 2022 | 91.57% |
| July 31, 2022 | 91.57% |
| June 30, 2022 | 91.57% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| SELLAS Life Sciences Group, Inc. | 99.94% |
| ACADIA Pharmaceuticals, Inc. | 77.18% |
| Alnylam Pharmaceuticals, Inc. | 58.17% |
| Anika Therapeutics, Inc. | 83.15% |
| Savara, Inc. | 97.41% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -58.59 |
| Beta (5Y) | 0.2098 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 89.00% |
| Historical Sharpe Ratio (5Y) | -0.6366 |
| Historical Sortino (5Y) | -1.227 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 32.81% |